Henry Schein Inc (HSIC) Stock Price, Quote & News

Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PP...

Industry: Medical Distribution

Sector: Healthcare

Phone: 631 843 5500

Website: www.henryschein.com

Address:

135 Duryea Road, Melville, United States

PrivateProfiteer Nov. 15 at 9:11 AM

$HSIC: The stock closed at $71.43, showing strength with an RSI of 70.97, indicating it is approaching overbought territory. The price is above both the 30-day MA of 66.21 and the 50-day MA of 66.73, suggesting a bullish trend. However, the high of $73.63 within the last 60 days presents a resistance level, while the low of $61.95 indicates a solid support base. Directional bias is cautiously bullish, but the high RSI signals potential for a pullback. Suggested trade plan: - Entry: $71.00 (slightly below the current close to confirm buying interest). - Stop: $69.50 (below the 30-day MA for risk management). - Target 1: $73.00 (near the 60D high). - Target 2: $74.00 (a psychological level above the recent high). Monitor for any signs of reversal as the RSI approaches overbought levels. https://privateprofiteers.com

0 · Reply

PrivateProfiteer Nov. 15 at 12:33 AM

$HSIC: The last close at $71.43 indicates a strong position within the recent trading range. With an RSI of 70.97, the stock is approaching overbought territory, suggesting potential for a pullback. The 30-day moving average (MA30) at $66.21 and 50-day moving average (MA50) at $66.73 indicate a bullish trend, as the current price is significantly above these averages. However, the proximity to the 60-day high of $73.63 raises caution for potential resistance. Directional bias is slightly bearish in the short term due to the high RSI, but the overall trend remains bullish. Suggested entry is at $70.50, with a stop loss at $69.00 to manage risk. Target 1 is set at $73.00, near the 60D high, and Target 2 at $74.00, allowing for a breakout scenario. Monitor price action closely for signs of reversal or continuation. https://privateprofiteers.com

0 · Reply

PrivateProfiteer Nov. 14 at 4:06 AM

$HSIC is currently trading at $73.34, close to its 60-day high of $73.63, indicating a strong bullish sentiment. The RSI at 77.62 suggests that the stock is in overbought territory, which may indicate a potential pullback. However, the price is above both the 30-day MA of 66.07 and the 50-day MA of 66.69, reinforcing a bullish trend in the short term. Given the current market context, a cautious approach is warranted. Suggested entry could be around $72.50, allowing for a potential dip. Set a stop loss at $71.00 to manage risk. For targets, consider $75.00 as the first target, aligning with the psychological resistance, and $76.00 as a second target, slightly above the 60-day high. Monitor the RSI for signs of reversal and adjust the plan accordingly. https://privateprofiteers.com

0 · Reply

SPYmyQQQ Nov. 13 at 9:02 PM

🚀 New Signal ✅ 🏛️ $HSIC 🗓️ Nov 13, 2025 💵 Entry: $73.35 🎯 Target (Opt.): $75.19 (+2.51%) 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

PrivateProfiteer Nov. 13 at 2:13 AM

$HSIC is currently trading at $73.22, near its 60-day high of $73.56, indicating strong upward momentum. The RSI at 79.16 suggests that the stock is overbought, which may lead to a pullback. The MA30 at 65.58 and MA50 at 66.46 indicate a bullish trend, but the high RSI raises caution for short-term traders. Directional bias leans bearish in the short term due to the overbought condition. Suggested entry could be around $72.50 to capitalize on a potential pullback. Set a stop loss at $71.00 to manage risk. Targets for this trade could be $74.00 as the first target, approaching the 60D high, and $75.00 as a second target if momentum continues post-correction. Overall, monitor for signs of reversal or further strength before entering. https://privateprofiteers.com

0 · Reply

PrivateProfiteer Nov. 12 at 1:49 AM

0 · Reply

ZZZZniiiiight Nov. 11 at 1:40 PM

$OMI I work in medical sales and this company is a dying one that’s for sure. Better to invest it $CAH or Medline once they IPO. $BX owns a major stake in it. Also $MCK and $HSIC would be better investments.

1 · Reply

wha1e Nov. 7 at 12:59 AM

$CMG $HSIC $BA $BE $TYL Jim Cramer’s take on these 5 stocks…

1 · Reply

IN0V8 Nov. 6 at 5:22 AM

$HSIC Leerink Partners raises target price to $75 from $70 Piper Sandler raises target price to $83 from $77 Wells Fargo raises target price to $76 from $70

0 · Reply

JarvisFlow Nov. 5 at 7:35 PM

JP Morgan has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Overweight with a target price of 76 → 78.

0 · Reply

Worried About an AI Bubble? Here Are BofA's Top Stock Picks to Diversify Your Portfolio

AMCR BGC CHD DG DIS ES FCX

Nov 13, 2025, 6:30 AM EST - 1 day ago

Henry Schein to Participate in Upcoming Investor Conference in December

Nov 12, 2025, 12:41 PM EST - 2 days ago

Henry Schein, Inc. (HSIC) Presents at Stifel 2025 Healthcare Conference Transcript

Nov 5, 2025, 8:05 AM EST - 9 days ago

VideaHealth and Henry Schein One Launch the Impact Panel, Bringing AI-Driven Patient Education to Dentrix and Dentrix Ascend

Nov 4, 2025, 12:56 PM EST - 10 days ago

Henry Schein Expands Strategic Partnership With KKR, Raises Annual Outlook

KKR

Nov 4, 2025, 11:56 AM EST - 10 days ago

Henry Schein, Inc. (HSIC) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 7:23 AM EST - 10 days ago

Henry Schein lifts annual forecast on strong dental, medical equipment sales

Nov 4, 2025, 6:00 AM EST - 11 days ago

Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance

Nov 3, 2025, 6:30 AM EST - 11 days ago

Henry Schein One and AWS Collaborate to Transform Global Dentistry with Generative AI

Oct 22, 2025, 6:30 AM EDT - 24 days ago

Henry Schein to Participate in Upcoming Investor Conferences in November

Oct 21, 2025, 6:30 AM EDT - 25 days ago

Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET

Oct 15, 2025, 10:30 AM EDT - 4 weeks ago

The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide

Sep 24, 2025, 9:43 AM EDT - 7 weeks ago

Henry Schein, Inc. (HSIC) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 16, 2025, 11:49 AM EDT - 2 months ago

Pearl Joins Henry Schein One API Exchange as an Authorized Integration Vendor

Sep 10, 2025, 1:16 PM EDT - 2 months ago

Henry Schein, Inc. (HSIC) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 5:10 PM EDT - 2 months ago

Henry Schein Announces $750 Million Share Repurchase Plan

Sep 9, 2025, 10:18 AM EDT - 2 months ago

Henry Schein Medical Expands SolutionsHub with Colaborate

Sep 4, 2025, 4:27 PM EDT - 2 months ago

Henry Schein, Inc. (HSIC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Aug 27, 2025, 8:00 AM EDT - 2 months ago

Worldpay & Henry Schein One: Exclusive Partnership Powers Dental Practices

Aug 22, 2025, 6:30 AM EDT - 3 months ago

Henry Schein to Participate in Upcoming Investor Conferences in September

Aug 19, 2025, 6:30 AM EDT - 3 months ago

Henry Schein's 28th Annual ‘Back to School' Program Supports Students Worldwide

Aug 14, 2025, 1:50 PM EDT - 3 months ago

Henry Schein: The Case For An Upgrade From Hold To Buy

Aug 5, 2025, 10:39 AM EDT - 3 months ago

Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 10:16 AM EDT - 3 months ago

Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution

Aug 5, 2025, 7:40 AM EDT - 3 months ago

Henry Schein falls after missing quarterly profit estimates

Aug 5, 2025, 6:00 AM EDT - 3 months ago

Henry Schein Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 1:24 PM EDT - 3 months ago

Henry Schein: Still Bullish Even As Shares Languish

Jul 30, 2025, 6:30 AM EDT - 3 months ago

Henry Schein One Launches Forms to Make Patient Check-In Easier and Faster

Jul 22, 2025, 6:30 AM EDT - 4 months ago

Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET

Jul 17, 2025, 9:16 AM EDT - 4 months ago

IntelePeer Joins Henry Schein One Academic Partner Program

Jul 15, 2025, 7:05 AM EDT - 4 months ago

Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

Jun 2, 2025, 6:45 PM EDT - 5 months ago

Updated: Henry Schein to Participate in Upcoming Investor Conference in June

May 20, 2025, 6:30 AM EDT - 6 months ago

Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

May 17, 2025, 9:30 AM EDT - 6 months ago

Henry Schein Post Earnings Review

May 16, 2025, 4:10 PM EDT - 6 months ago

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

May 15, 2025, 6:30 AM EDT - 6 months ago

Henry Schein to Participate in Upcoming Investor Conference in June

May 6, 2025, 9:36 AM EDT - 6 months ago

These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results

May 6, 2025, 6:30 AM EDT - 6 months ago

Henry Schein to Participate in Upcoming Investor Conferences in May

May 5, 2025, 4:26 PM EDT - 6 months ago

Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript

May 5, 2025, 8:49 AM EDT - 6 months ago

Henry Schein misses quarterly revenue estimates on weak demand for dental products

May 5, 2025, 6:00 AM EDT - 6 months ago

Henry Schein Reports First Quarter 2025 Financial Results

Apr 22, 2025, 6:30 AM EDT - 7 months ago

Henry Schein Medical Announces Winner of Its 2025 Rising Star Award

Apr 8, 2025, 6:30 AM EDT - 7 months ago

Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET

Apr 7, 2025, 6:30 AM EDT - 7 months ago

Henry Schein Received Validation of Net-Zero Science-Based Targets

Mar 31, 2025, 9:30 AM EDT - 8 months ago

IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor

Mar 25, 2025, 9:00 AM EDT - 8 months ago

Henry Schein Will Showcase a Selection of the Company's Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show

Mar 11, 2025, 6:30 AM EDT - 8 months ago

Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year

Mar 11, 2025, 4:25 AM EDT - 8 months ago

Henry Schein Looks Bullish (Technical Analysis)

Mar 4, 2025, 5:57 PM EST - 9 months ago

Henry Schein: An Industry Leader That Offers Some Upside From Here

Mar 3, 2025, 6:30 AM EST - 9 months ago

Henry Schein to Participate in Upcoming Investor Conference in March

PrivateProfiteer Nov. 15 at 9:11 AM

0 · Reply

PrivateProfiteer Nov. 15 at 12:33 AM

0 · Reply

PrivateProfiteer Nov. 14 at 4:06 AM

0 · Reply

SPYmyQQQ Nov. 13 at 9:02 PM

🚀 New Signal ✅ 🏛️ $HSIC 🗓️ Nov 13, 2025 💵 Entry: $73.35 🎯 Target (Opt.): $75.19 (+2.51%) 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

PrivateProfiteer Nov. 13 at 2:13 AM

0 · Reply

PrivateProfiteer Nov. 12 at 1:49 AM

0 · Reply

ZZZZniiiiight Nov. 11 at 1:40 PM

1 · Reply

wha1e Nov. 7 at 12:59 AM

$CMG $HSIC $BA $BE $TYL Jim Cramer’s take on these 5 stocks…

1 · Reply

IN0V8 Nov. 6 at 5:22 AM

$HSIC Leerink Partners raises target price to $75 from $70 Piper Sandler raises target price to $83 from $77 Wells Fargo raises target price to $76 from $70

0 · Reply

JarvisFlow Nov. 5 at 7:35 PM

JP Morgan has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Overweight with a target price of 76 → 78.

0 · Reply

JarvisFlow Nov. 5 at 6:46 PM

Barrington Research has updated their rating for Henry Schein ( $HSIC ) to Outperform with a price target of 79.

0 · Reply

JarvisFlow Nov. 5 at 6:09 PM

Morgan Stanley has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Underweight with a target price of 55 → 58.

0 · Reply

JarvisFlow Nov. 5 at 3:13 PM

Wells Fargo has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Equal-Weight with a target price of 70 → 76.

0 · Reply

JarvisFlow Nov. 5 at 2:12 PM

Evercore ISI Group has updated their rating for Henry Schein ( $HSIC ) to Outperform with a price target of 90.

0 · Reply

AStrokeOfLuck Nov. 4 at 2:57 PM

$HSIC

0 · Reply

OptionRunners Nov. 4 at 1:59 PM

$HSIC +10% on earnings

0 · Reply

ZacksResearch Nov. 4 at 1:58 PM

$HSIC beats earnings and raises 2025 guidance! 🚀 Adjusted EPS up 13.1% YoY, surpassing the Zacks Consensus Estimate by 8.7%. Sales growth driven by strong performance across segments, with notable growth in Global Distribution and Value-Added Services 📈. Discover full insights and what’s next for HSIC 👉 https://www.zacks.com/stock/news/2784385/hsic-stock-jumps-on-q3-earnings-and-revenue-beat-25-outlook-up?cid=sm-stocktwits-2-2784385-body-19244&ADID=SYND_STOCKTWITS_TWEET_2_2784385_BODY_19244

0 · Reply

OpenOutcrier Nov. 4 at 1:26 PM

$HSIC (+8.0% pre) HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up https://ooc.bz/l/83000

0 · Reply

ZacksResearch Nov. 4 at 12:58 PM

$HSIC pops after a strong Q3 beat 🚀 Earnings and revenue topped estimates, and management lifted its 2025 outlook — clear signs of solid business momentum ahead. See the full earnings recap here 👉 https://www.zacks.com/stock/news/2784385/hsic-stock-jumps-on-q3-earnings-and-revenue-beat-25-outlook-up?cid=sm-stocktwits-2-2784385-teaser-19243&ADID=SYND_STOCKTWITS_TWEET_2_2784385_TEASER_19243

1 · Reply

John_Wick1234 Nov. 4 at 12:19 PM

$HSIC Nice Double Bottom with Volume.

0 · Reply

DonCorleone77 Nov. 4 at 11:36 AM

$HSIC Henry Schein reports Q3 adjusted EPS $1.38, consensus $1.28 -- Q3 revenue $3.34B, consensus $3.28B. -- Raises FY25 adjusted EPS view to $4.88-$4.96 from $4.80-$4.94, consensus $4.82. -- FY25 2025 total sales growth is raised to be approximately 3% to 4% over 2024, previously 2% to 4% total sales growth.

0 · Reply

lee305 Nov. 3 at 6:14 PM

$ZBH $BDX $BAX $HSIC $EW yall need to get your act together and start consolidating.

0 · Reply

Market Cap	8.63B
Revenue (ttm)	12.67B
Net Income (ttm)	390.00M
EPS (ttm)	N/A
PE Ratio	15.11
Forward PE	14.82
Profit Margin	3.08%
Debt to Equity Ratio	0.54

Volume	1,499,800
Avg Vol	1,594,342
Day's Range	N/A - N/A
Shares Out	117.73M
Stochastic %K	61%
Beta	0.84
Analysts	Sell
Price Target	$77.00